Related Experiment Video
Updated: Mar 23, 2026

Seven Steps to Stellate Cells
Published on: May 10, 2011
Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis
Mio Kitano1, P Mark Bloomston2
1Division of Surgical Oncology, Department of Surgery, Wexner Medical Center, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA. kitmio@gmail.com.
Abstract:
microRNAs (miRNAs) are small non-coding RNAs that regulate gene expression by either blocking translation or inducing degradation of target mRNA. miRNAs play essential roles in diverse biological and pathological processes, including development of hepatic fibrosis. Hepatic stellate cells (HSCs) play a central role in development of hepatic fibrosis and there are intricate regulatory effects of miRNAs on their activation, proliferation, collagen production, migration, and apoptosis. There are multiple differentially expressed miRNAs in activated HSCs, and in this review we aim to summarize current data on miRNAs that participate in the development of hepatic fibrosis. Based on this review, miRNAs may serve as biomarkers for diagnosis of liver disease, as well as markers of disease progression. Most importantly, dysregulated miRNAs may potentially be targeted by novel therapies to treat and reverse progression of hepatic fibrosis.
Insights
MicroRNAs (miRNAs) regulate gene expression and are crucial in liver fibrosis. This review highlights miRNAs in hepatic stellate cell activation, offering potential diagnostic biomarkers and therapeutic targets for liver disease.
Area of Science:
- Molecular Biology
- Genetics
- Hepatology
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression.
- Hepatic fibrosis is a pathological process involving complex biological mechanisms.
- Hepatic stellate cells (HSCs) are key players in liver fibrosis development.
Purpose of the Study:
- To review and summarize current data on miRNAs involved in hepatic fibrosis.
- To explore the regulatory roles of miRNAs in HSC activation, proliferation, collagen production, migration, and apoptosis.
- To discuss the potential of miRNAs as diagnostic biomarkers and therapeutic targets for liver fibrosis.
Main Methods:
- Literature review of scientific articles on miRNAs and hepatic fibrosis.
- Analysis of differentially expressed miRNAs in activated HSCs.
- Synthesis of current knowledge on miRNA functions in liver fibrosis pathogenesis.
Main Results:
- Multiple miRNAs are differentially expressed in activated HSCs.
- miRNAs intricately regulate HSC functions, influencing liver fibrosis progression.
- Dysregulated miRNAs are implicated in the development and progression of hepatic fibrosis.
Conclusions:
- miRNAs play significant roles in hepatic fibrosis development.
- miRNAs show potential as biomarkers for liver disease diagnosis and progression monitoring.
- Targeting dysregulated miRNAs may offer novel therapeutic strategies for treating hepatic fibrosis.
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Liver Histology
Hepatocytes perform a variety of essential functions. They secrete...

